1. Home
  2. Tumor marker
  Subject:

Tumor marker   New Search

View on DBpedia    View on Wikipedia
Top related subjects:
RELATED SUBJECTS:
The publications listed also have these subjects
Ovarian cancer  5 times
Carcinoma  4 times
Immunoassay  3 times
Biopsy  3 times
Adenocarcinoma  3 times
Pancreatic cancer  2 times
Odds ratio  2 times
Electrochemiluminescence  2 times
Cytokeratin  2 times
CT scan  2 times
CA19-9  2 times
CA-125  2 times
Blood plasma  2 times
White blood cell  1 time
Vitamin K  1 time
Venous thrombosis  1 time
Thyroidectomy  1 time
Thyroid  1 time
Tachycardia  1 time
Syndrome  1 time
Stomach cancer  1 time
Serum albumin  1 time
Regression analysis  1 time
Receiver operating characteristic  1 time
Real-time polymerase chain reaction  1 time
Radioligand  1 time
Quality control  1 time
Quadrupole mass analyzer  1 time
Proteinuria  1 time
Prostate-specific antigen  1 time
Prostate cancer  1 time
Progression-free survival  1 time
Positron  1 time
Pleural effusion  1 time
Platelet  1 time
Peripheral neuropathy  1 time
Pericardial effusion  1 time
Peptide  1 time
Pathognomonicity  1 time
PTPRC  1 time
P-value  1 time
Necrosis  1 time
Multivariate analysis  1 time
Metastasis  1 time
Metalloproteinase  1 time
Mass spectrometry  1 time
Lymphocytopenia  1 time
Lymph node  1 time
Lactate dehydrogenase  1 time
Japan  1 time
Intron  1 time
Immunohistochemistry  1 time
Immunoglobulin G  1 time
Glycan  1 time
Germ cell tumor  1 time
Gene therapy  1 time
Gene  1 time
Gemcitabine  1 time
Fluorescence  1 time
Flow cytometry  1 time
Fibroblast  1 time
Enzyme inhibitor  1 time
Enolase  1 time
Endoscopy  1 time
Embolism  1 time
Effusion  1 time
Echocardiography  1 time
Cytopathology  1 time
Colorectal cancer  1 time
Cirrhosis  1 time
Chronic pancreatitis  1 time
Chromatography  1 time
Cardiac tamponade  1 time
Carcinoembryonic antigen  1 time
Calcium  1 time
Calcitonin  1 time
Bilirubin  1 time
Asteroid family  1 time
Antigen  1 time
Antibody  1 time
Alpha-fetoprotein  1 time
Algorithm  1 time
Alanine transaminase  1 time

Publications tagged with this subject: 16

Note: Top 50 publications shown only. Open an item panel to view more info (open all)


1. Advances in rare cell isolation: an optimization and evaluation study

2. Naturally occurring anti-glycan antibodies binding to Globo H-expressing cells identify ovarian cancer patients

3. Comparison of platelet-lymphocyte ratio and CA 19-9 in differentiating benign from malignant head masses in patients with chronic pancreatitis

4. Does “OPTINAB” strategy (“stop-and-go”) work in treatment of advanced pancreatic cancer (APC) with nab-paclitaxel–gemcitabine?

5. Serum calcitonin reference values for calcium stimulation tests by electrochemiluminescence immunoassay in Japanese men with non-medullary thyroid carcinoma

6. The Value of MiR-383, an Intronic MiRNA, as a Diagnostic and Prognostic Biomarker in Intestinal-Type Gastric Cancer

7. A quantitative analytical method for PIVKA-II using multiple reaction monitoring-mass spectrometry for early diagnosis of hepatocellular carcinoma

8. Is neuron-specific enolase useful for diagnosing malignant pleural effusions? evidence from a validation study and meta-analysis

9. Selecting treatment method for ovarian masses in children – 24 years of experience

10. The value of the new scoring system for predicting neoplastic pericarditis in the patients with large pericardial effusion

11. Utility of (18) F-FDG PET/CT and CECT in conjunction with serum CA 19-9 for detecting recurrent pancreatic adenocarcinoma

12. Plasma levels of MMP-7 and TIMP-1 in laboratory diagnostics and differentiation of selected histological types of epithelial ovarian cancers

13. Association between Level of Tumor Markers and Development of VTE in Patients with Pancreatic, Colorectal and Ovarian Ca: Retrospective Case- Control Study in Two Community Hospitals

14. Alpha–fetoprotein elevation in NUT midline carcinoma: a case report

15. Caspase-Cleaved Cytokeratin 18 Fragment M30 as a Potential Biomarker of Macrovascular Invasion in Hepatocellular Carcinoma

16. Overall survival and response pattern of castration-resistant metastatic prostate cancer to multiple cycles of radioligand therapy using [177Lu]Lu-PSMA-617


Questions?

Drop us a message.